The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has bestowed its 2025 Georg Charles de Hevesy Nuclear Pioneer award on Wynn Volkert, PhD.
Wynn Volkert, PhD.
Volkert is Emeritus Distinguished Curators Professor of radiology and chemistry at the University of Missouri (MU). He has served as director of the Radiopharmaceutical Sciences Institute at MU and as research career scientist at the H.S. Truman Memorial VA Hospital in Columbia, MO. He was director/principal investigator of the National Institutes of Health (NIH)-funded MU In Vivo Cellular and Molecular Imaging Center.
He is a co-inventor of two radiolabeled molecular entities that were developed into U.S. Food and Drug Administration (FDA)-approved radiopharmaceuticals for routine use in patients: Ceretec, a technetium-99m (Tc-99m) brain imaging agent, and Quadramet, a samarium-153 therapeutic agent.
Volkert earned his doctorate in chemistry and radiochemistry from the University of Missouri-Columbia and has spent more than 40 years in research and has authored or co-authored 185 original articles, primarily related to the fields of radiopharmaceutical chemistry and nuclear medicine.
